天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

2-Pyridinecarboxamide, 6-fluoro-N-methyl-5-(1-piperazinyl)-

2-Pyridinecarboxamide, 6-fluoro-N-methyl-5-(1-piperazinyl)- Struktur
2589531-50-8
CAS-Nr.
2589531-50-8
Englisch Name:
2-Pyridinecarboxamide, 6-fluoro-N-methyl-5-(1-piperazinyl)-
Synonyma:
6-Fluoro-N-methyl-5-(1-piperazinyl)-2-pyridinecarboxamide;2-Pyridinecarboxamide, 6-fluoro-N-methyl-5-(1-piperazinyl)-
CBNumber:
CB510753005
Summenformel:
C11H15FN4O
Molgewicht:
238.26
MOL-Datei:
2589531-50-8.mol

2-Pyridinecarboxamide, 6-fluoro-N-methyl-5-(1-piperazinyl)- Eigenschaften

Siedepunkt:
438.9±45.0 °C(Predicted)
Dichte
1.218±0.06 g/cm3(Predicted)
pka
13.28±0.46(Predicted)

Sicherheit

2-Pyridinecarboxamide, 6-fluoro-N-methyl-5-(1-piperazinyl)- Chemische Eigenschaften,Einsatz,Produktion Methoden

2-Pyridinecarboxamide, 6-fluoro-N-methyl-5-(1-piperazinyl)- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


2-Pyridinecarboxamide, 6-fluoro-N-methyl-5-(1-piperazinyl)- Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 7)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Wuhan Jingkang en Biomedical Technology Co., Ltd
+8613720134139
orders@jknbiochem.com China 5221 58
Shandong Zhonghan Pharmaceutical Co.,Ltd. 15066662237 15066662237
3281004549@qq.com China 208 55
Shanghai Subo Pharmaceutical Technology Co., Ltd. 021-54156369 16621315851
yhsuyiming@126.com China 275 58
Chengdu PEIP Pharmaceutical Technology Co., LTD. 028-61715638 18011352545
1242335275@qq.com China 363 58
Shanghai Haohong Pharmaceutical Co., Ltd. 400-400-8210725 4008210725
malulu@leyan.com China 40000 58
Wuhan Jingkangen Biomedical Technology Co., Ltd 13720134139 13720134139
orders@jknbiochem.com China 5822 58
Shanghai AMINO Biotechnology Co., Ltd 17302153218
1743952078@qq.com China 694 58

  • 2-Pyridinecarboxamide, 6-fluoro-N-methyl-5-(1-piperazinyl)-
  • 6-Fluoro-N-methyl-5-(1-piperazinyl)-2-pyridinecarboxamide
  • 2589531-50-8
Copyright 2019 ? ChemicalBook. All rights reserved